These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25613081)

  • 1. Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort.
    Katsumata Y; Mathews M; Abner EL; Jicha GA; Caban-Holt A; Smith CD; Nelson PT; Kryscio RJ; Schmitt FA; Fardo DW
    Dement Geriatr Cogn Disord; 2015; 39(3-4):215-27. PubMed ID: 25613081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston Naming Test: shortened versions for use in Alzheimer's disease.
    Mack WJ; Freed DM; Williams BW; Henderson VW
    J Gerontol; 1992 May; 47(3):P154-8. PubMed ID: 1573197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer's dementia and mild cognitive impairment: clinical and biomarker correlates.
    Aniwattanapong D; Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Tawankanjanachot I; Chuchuen P; Snabboon T; Carvalho AF; Maes M
    Aging Ment Health; 2019 Jul; 23(7):840-850. PubMed ID: 30351202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boston Naming Test in Alzheimer's disease.
    Williams BW; Mack W; Henderson VW
    Neuropsychologia; 1989; 27(8):1073-9. PubMed ID: 2797414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Danish adaptation of the Boston Naming Test: preliminary norms for older adults and validity in mild Alzheimer's disease.
    Jørgensen K; Johannsen P; Vogel A
    Clin Neuropsychol; 2017; 31(sup1):72-87. PubMed ID: 28854839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picture-naming test for a linguistically diverse population with cognitive impairment and dementia.
    Paplikar A; Varghese F; Alladi S; Vandana VP; Darshini KJ; Iyer GK; Kandukuri R; Divyaraj G; Sharma M; Dhaliwal RS; Kaul S; Saroja AO; Ghosh A; Sunitha J; Khan AB; Mathew R; Mekala S; Menon R; Nandi R; Narayanan J; Nehra A; Padma MV; Pauranik A; Ramakrishnan S; Sarath L; Shah U; Tripathi M; Sylaja PN; Varma RP; Verma M; Vishwanath Y;
    Int J Lang Commun Disord; 2022 Jul; 57(4):881-894. PubMed ID: 35522006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Boston naming test short forms in a rehabilitation sample.
    Attridge J; Zimmerman D; Rolin S; Davis JJ
    Appl Neuropsychol Adult; 2022; 29(4):810-815. PubMed ID: 32841074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Multilingual Naming Test (MINT) as a Measure of Picture Naming Ability in Alzheimer's Disease.
    Stasenko A; Jacobs DM; Salmon DP; Gollan TH
    J Int Neuropsychol Soc; 2019 Sep; 25(8):821-833. PubMed ID: 31248465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boston naming test short forms: a comparison of previous forms with new item response theory based forms.
    Graves RE; Bezeau SC; Fogarty J; Blair R
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):891-902. PubMed ID: 15742540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boston Naming Test (BNT) original, Brazilian adapted version and short forms: normative data for illiterate and low-educated older adults.
    Leite KS; Miotto EC; Nitrini R; Yassuda MS
    Int Psychogeriatr; 2017 May; 29(5):825-833. PubMed ID: 27876103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boston Naming Test automatic credits inflate scores of nonaphasic mild dementia patients.
    Stålhammar J; Rydén I; Nordlund A; Wallin A
    J Clin Exp Neuropsychol; 2016; 38(4):381-92. PubMed ID: 26702791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
    Li D; Yu YY; Hu N; Zhang M; Sun FL; Liu L; Fan LM; Ruan SS; Wang F; Rosa-Neto P
    J Alzheimers Dis; 2023; 94(1):393-404. PubMed ID: 37248898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded Exploration of the Auditory Naming Test in Patients with Dementia.
    Hirsch JA; Cuesta GM; Fonzetti P; Comaty J; Jordan BD; Cirio R; Levin L; Abrahams A; Fry KM
    J Alzheimers Dis; 2021; 81(4):1763-1779. PubMed ID: 33998546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Stability of Mild Cognitive Impairment (MCI): Findings of a Community Based Sample.
    Ellendt S; Voβ B; Kohn N; Wagels L; Goerlich KS; Drexler E; Schneider F; Habel U
    Curr Alzheimer Res; 2017; 14(6):608-619. PubMed ID: 27978792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spanish multicenter normative studies (NEURONORMA project): normative data and equivalence of four BNT short-form versions.
    Casals-Coll M; Sánchez-Benavides G; Meza-Cavazos S; Manero RM; Aguilar M; Badenes D; Molinuevo JL; Robles A; Barquero MS; Antúnez C; Martínez-Parra C; Frank-García A; Fernández M; Blesa R; Peña-Casanova J;
    Arch Clin Neuropsychol; 2014 Feb; 29(1):60-74. PubMed ID: 24217861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.